“Inflammaging” as a Druggable Target: A Senescence-Associated Secretory Phenotype—Centered View of Type 2 Diabetes
暂无分享,去创建一个
Fabiola Olivieri | Antonio Domenico Procopio | Antonio Ceriello | A. Procopio | A. Ceriello | F. Olivieri | F. Prattichizzo | L. La Sala | V. De Nigris | Francesco Prattichizzo | Valeria De Nigris | Lucia La Sala
[1] Bertrand Friguet,et al. NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases , 2015, Redox biology.
[2] Linda Partridge,et al. Minireview Stress-response Hormesis and Aging: ''that Which Does Not Kill Us Makes Us Stronger'' Figure 1. Dose-response Curve of a Treatment with a Hormetic Effect Minireview Cell Metabolism , 2022 .
[3] K. Rudolph,et al. DNA damage checkpoints in stem cells, ageing and cancer , 2012, Nature Reviews Molecular Cell Biology.
[4] M. Vandewoude,et al. Where frailty meets diabetes , 2016, Diabetes/metabolism research and reviews.
[5] R. Testa,et al. Leukocyte telomere length is associated with complications of Type 2 diabetes mellitus , 2011, Diabetic medicine : a journal of the British Diabetic Association.
[6] Manuel Serrano,et al. The Hallmarks of Aging , 2013, Cell.
[7] J. Diehl,et al. Coordination of ER and oxidative stress signaling: the PERK/Nrf2 signaling pathway. , 2006, The international journal of biochemistry & cell biology.
[8] Jennifer G. Robinson,et al. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis , 2012, The Lancet.
[9] L. Rodríguez-Mañas,et al. Endothelial dysfunction in aged humans is related with oxidative stress and vascular inflammation , 2009, Aging cell.
[10] A. Salminen,et al. Emerging role of NF-κB signaling in the induction of senescence-associated secretory phenotype (SASP). , 2012, Cellular signalling.
[11] C. Yabe-Nishimura,et al. ROS‐generating oxidases Nox1 and Nox4 contribute to oncogenic Ras‐induced premature senescence , 2013, Genes to cells : devoted to molecular & cellular mechanisms.
[12] J. Melendez,et al. Redox Control of the Senescence Regulator Interleukin-1α and the Secretory Phenotype* , 2013, The Journal of Biological Chemistry.
[13] P. Nilsson,et al. Association of Insulin Resistance, Arterial Stiffness and Telomere Length in Adults Free of Cardiovascular Diseases , 2015, PloS one.
[14] L. Zender,et al. mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype , 2015, Nature Cell Biology.
[15] M. Donath. Targeting inflammation in the treatment of type 2 diabetes: time to start , 2014, Nature Reviews Drug Discovery.
[16] G. Deferrari,et al. Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy. , 2008, American journal of physiology. Renal physiology.
[17] D. Ingram,et al. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. , 2013, Cell metabolism.
[18] L. Rodella,et al. Endothelium and Its Alterations in Cardiovascular Diseases: Life Style Intervention , 2014, BioMed research international.
[19] S. Malozowski,et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. , 2007, The New England journal of medicine.
[20] K. Ligon,et al. p16INK4a induces an age-dependent decline in islet regenerative potential , 2006, Nature.
[21] P. Rabinovitch,et al. mTOR is a key modulator of ageing and age-related disease , 2013, Nature.
[22] M. Marquès,et al. Adipose Tissue Endothelial Cells From Obese Human Subjects: Differences Among Depots in Angiogenic, Metabolic, and Inflammatory Gene Expression and Cellular Senescence , 2010, Diabetes.
[23] M. Crabtree,et al. Prevention and Reversal of Premature Endothelial Cell Senescence and Vasculopathy in Obesity-Induced Diabetes by Ebselen , 2004, Circulation research.
[24] A. Ceriello. The emerging challenge in diabetes: the "metabolic memory". , 2012, Vascular pharmacology.
[25] R. Goldman,et al. β‐Galactosidase—An indicator of the maturational stage of mouse and human mononuclear phagocytes , 1982, Journal of cellular physiology.
[26] A. Alimonti,et al. Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer. , 2016, Trends in cell biology.
[27] F. Foufelle,et al. New insights into ER stress-induced insulin resistance , 2012, Trends in Endocrinology & Metabolism.
[28] M. Shestakova,et al. Short telomere length is associated with arterial aging in patients with type 2 diabetes mellitus , 2015, Endocrine connections.
[29] P. Jena,et al. Understanding and modulating the Toll like Receptors (TLRs) and NOD like Receptors (NLRs) cross talk in type 2 diabetes. , 2014, Current diabetes reviews.
[30] N. LeBrasseur,et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders , 2011, Nature.
[31] Marco Pahor,et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice , 2009, Nature.
[32] J. Campisi,et al. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. , 2013, The Journal of clinical investigation.
[33] N. Sharpless,et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice , 2015, Nature Medicine.
[34] N. LeBrasseur,et al. Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity , 2015, Diabetes.
[35] Frank Reimann,et al. Diabetes Recovery By Age-Dependent Conversion of Pancreatic δ-Cells Into Insulin Producers , 2014, Nature.
[36] D. Peeper,et al. Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network , 2008, Cell.
[37] Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes , 2015, Clinical Epigenetics.
[38] L. Ferrucci,et al. Interleukin-6 in aging and chronic disease: a magnificent pathway. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.
[39] K. Maiese. New Insights for Oxidative Stress and Diabetes Mellitus , 2015, Oxidative medicine and cellular longevity.
[40] R. Testa,et al. Pathogenetic Loop Between Diabetes and Cell Senescence , 2007, Diabetes Care.
[41] Stefanie Dimmeler,et al. Antioxidants Inhibit Nuclear Export of Telomerase Reverse Transcriptase and Delay Replicative Senescence of Endothelial Cells , 2004, Circulation research.
[42] J. Tschopp,et al. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? , 2010, Nature Reviews Immunology.
[43] C. Franceschi,et al. Inflamm‐aging: An Evolutionary Perspective on Immunosenescence , 2000 .
[44] P. Defossez,et al. Screening of a kinase library reveals novel pro-senescence kinases and their common NF-κB-dependent transcriptional program , 2015, Aging.
[45] J. Cooke,et al. Meal-induced increases in C-reactive protein, interleukin-6 and tumour necrosis factor α are attenuated by prandial + basal insulin in patients with Type 2 diabetes , 2011, Diabetic medicine : a journal of the British Diabetic Association.
[46] F. J. Romero,et al. Diabetes and the Brain: Oxidative Stress, Inflammation, and Autophagy , 2014, Oxidative medicine and cellular longevity.
[47] Jennifer Y. Liu,et al. Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study. , 2014, JAMA internal medicine.
[48] T. Asano,et al. Blockade of the Nuclear Factor-&kgr;B Pathway in the Endothelium Prevents Insulin Resistance and Prolongs Life Spans , 2012, Circulation.
[49] C. Franceschi,et al. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.
[50] A. Pezeshki,et al. Naturally occurring p16Ink4a-positive cells shorten healthy lifespan , 2016, Nature.
[51] W. Aird. Endothelial cell heterogeneity and atherosclerosis , 2006, Current atherosclerosis reports.
[52] M. Goligorsky,et al. Endothelium under stress: local and systemic messages. , 2012, Seminars in nephrology.
[53] Michael B. Stadler,et al. Aging-Dependent Demethylation of Regulatory Elements Correlates with Chromatin State and Improved β Cell Function. , 2015, Cell metabolism.
[54] D. Magne,et al. Inflammation: a culprit for vascular calcification in atherosclerosis and diabetes , 2015, Cellular and Molecular Life Sciences.
[55] P. Petocz,et al. High-glycemic index carbohydrate increases nuclear factor-kappaB activation in mononuclear cells of young, lean healthy subjects. , 2008, The American journal of clinical nutrition.
[56] K. Sharma,et al. The endoplasmic reticulum stress response and diabetic kidney disease. , 2011, American journal of physiology. Renal physiology.
[57] Elias Lolis,et al. Structure, function, and inhibition of chemokines. , 2002, Annual review of pharmacology and toxicology.
[58] A. Kruger,et al. Gene expression profiling of replicative and induced senescence , 2014, Cell cycle.
[59] J. Peters,et al. The Nuclear Receptor Peroxisome Proliferator-activated Receptor-β/δ (PPARβ/δ) Promotes Oncogene-induced Cellular Senescence through Repression of Endoplasmic Reticulum Stress* , 2014, The Journal of Biological Chemistry.
[60] T. Spector,et al. Omics technologies and the study of human ageing , 2013, Nature Reviews Genetics.
[61] R. Testa,et al. Leukocyte telomere shortening in elderly Type2DM patients with previous myocardial infarction. , 2009, Atherosclerosis.
[62] R. Testa,et al. The pivotal role of high glucose-induced overexpression of PKCβ in the appearance of glucagon-like peptide-1 resistance in endothelial cells , 2016, Endocrine.
[63] R. Marfella,et al. Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress , 2002, Circulation.
[64] J. Weissman,et al. Regulated Ire1-dependent decay of messenger RNAs in mammalian cells , 2009, The Journal of cell biology.
[65] S. Gruber,et al. Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway , 2006, Nature Cell Biology.
[66] Luigi Fabrizio Rodella,et al. Metabolic syndrome, aging and involvement of oxidative stress. , 2015, Aging and disease.
[67] B. S. Mohammed,et al. Endoplasmic Reticulum Stress Is Reduced in Tissues of Obese Subjects After Weight Loss , 2009, Diabetes.
[68] R. Busse,et al. Endothelial aging. , 2005, Cardiovascular research.
[69] E. Blackburn,et al. Short Leukocyte Telomere Length Predicts Risk of Diabetes in American Indians: the Strong Heart Family Study , 2013, Diabetes.
[70] D. Seals,et al. Aging is associated with greater nuclear NFκB, reduced IκBα, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humans , 2008, Aging cell.
[71] P. Ridker. From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection. , 2016, Circulation research.
[72] R. Testa,et al. Evidence That Hyperglycemia After Recovery From Hypoglycemia Worsens Endothelial Function and Increases Oxidative Stress and Inflammation in Healthy Control Subjects and Subjects With Type 1 Diabetes , 2012, Diabetes.
[73] Judith Campisi,et al. Cell surface-bound IL-1α is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network , 2009, Proceedings of the National Academy of Sciences.
[74] Gastone Castellani,et al. Remodelling of biological parameters during human ageing: evidence for complex regulation in longevity and in type 2 diabetes , 2011, AGE.
[75] M. Jensen,et al. JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age , 2015, Proceedings of the National Academy of Sciences.
[76] P. Dentelli,et al. p53 Mediates the Accelerated Onset of Senescence of Endothelial Progenitor Cells in Diabetes* , 2006, Journal of Biological Chemistry.
[77] L. Ferrucci,et al. Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet. , 2013, Cell metabolism.
[78] D. Baker,et al. Cellular senescence in aging and age-related disease: from mechanisms to therapy , 2015, Nature Medicine.
[79] Jung Jae Shin,et al. Damage-associated molecular patterns and their pathological relevance in diabetes mellitus , 2015, Ageing Research Reviews.
[80] Arisa Higa,et al. Redox signaling loops in the unfolded protein response. , 2012, Cellular signalling.
[81] A. Baranova,et al. Age-independent rise of inflammatory scores may contribute to accelerated aging in multi-morbidity , 2015, Oncotarget.
[82] A. D. de Craen,et al. The number of p16INK4a positive cells in human skin reflects biological age , 2012, Aging cell.
[83] D. Cai,et al. Hypothalamic Programming of Systemic Aging Involving IKKβ/NF-κB and GnRH , 2013, Nature.
[84] M. A. Sotomayor,et al. Endothelial dysfunction and aging: An update , 2010, Ageing Research Reviews.
[85] J. Campisi,et al. p38MAPK is a novel DNA damage response‐independent regulator of the senescence‐associated secretory phenotype , 2011, The EMBO journal.
[86] Luca Tiano,et al. Anti-TNF-α treatment modulates SASP and SASP-related microRNAs in endothelial cells and in circulating angiogenic cells , 2016, Oncotarget.
[87] L. Almasy,et al. GENOME-WIDE LINKAGE ANALYSIS OF CAROTID ARTERY LUMEN DIAMETER IN AMERICAN INDIANS: THE STRONG HEART FAMILY STUDY , 2012 .
[88] J. Campisi,et al. Inflammatory networks during cellular senescence: causes and consequences. , 2010, Trends in molecular medicine.
[89] J. Hensen,et al. Impact of interleukin-1β antibody (canakinumab) on glycaemic indicators in patients with type 2 diabetes mellitus: results of secondary endpoints from a randomized, placebo-controlled trial. , 2013, Diabetes & metabolism.
[90] Laura C. Greaves,et al. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice , 2014, Nature Communications.
[91] M. Cooper,et al. Epigenetics: Mechanisms and Implications for Diabetic Complications , 2010, Circulation research.
[92] Soyoung Lee,et al. Synthetic lethal metabolic targeting of cellular senescence in cancer therapy , 2013, Nature.
[93] Leonid Peshkin,et al. Resveratrol prevents high fat/sucrose diet-induced central arterial wall inflammation and stiffening in nonhuman primates. , 2014, Cell metabolism.
[94] C. Herder,et al. The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications , 2015, Trends in Endocrinology & Metabolism.
[95] C. Franceschi,et al. Anti-inflammatory effect of ubiquinol-10 on young and senescent endothelial cells via miR-146a modulation. , 2013, Free radical biology & medicine.
[96] P. Libby,et al. Effects of Interleukin-1&bgr; Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen: A Phase IIb Randomized, Placebo-Controlled Trial , 2012, Circulation.
[97] Kelly J. Morris,et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence , 2013, Nature Cell Biology.
[98] Qiang Feng,et al. A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.
[99] D. Peeper,et al. The essence of senescence. , 2010, Genes & development.
[100] R. Kitsis,et al. MacroH2A1 and ATM Play Opposing Roles in Paracrine Senescence and the Senescence-Associated Secretory Phenotype. , 2015, Molecular cell.
[101] M. Jensen,et al. Fat tissue, aging, and cellular senescence , 2010, Aging cell.
[102] M. Bonafè,et al. Endothelial Cell Senescence and Inflammaging: MicroRNAs as Biomarkers and Innovative Therapeutic Tools. , 2016, Current drug targets.
[103] S. Henson,et al. Are senescence and exhaustion intertwined or unrelated processes that compromise immunity? , 2011, Nature Reviews Immunology.
[104] G. Tamma,et al. Oxidative Medicine and Cellular Longevity , 2018 .
[105] L. Velloso,et al. Endoplasmic reticulum stress, obesity and diabetes. , 2012, Trends in molecular medicine.
[106] M. Blagosklonny. TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists , 2013, Cell Death and Disease.
[107] P. Nelson,et al. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation , 2015, Nature Cell Biology.
[108] Kate Schroder,et al. The NLRP3 Inflammasome: A Sensor for Metabolic Danger? , 2010, Science.
[109] B. Fei,et al. Metformin Beyond Diabetes: Pleiotropic Benefits of Metformin in Attenuation of Atherosclerosis , 2014, Journal of the American Heart Association.
[110] J. Manson,et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. , 2008, JAMA.
[111] Xiyan Li,et al. mTOR-mediated dedifferentiation of the retinal pigment epithelium initiates photoreceptor degeneration in mice. , 2011, The Journal of clinical investigation.
[112] Toshio Ogihara,et al. Apoptosis Signal-Regulating Kinase 1 Mediates Cellular Senescence Induced by High Glucose in Endothelial Cells , 2006, Diabetes.
[113] P. Pandolfi,et al. Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity. , 2014, Cell reports.
[114] Karen Block,et al. Mammalian Target of Rapamycin Regulates Nox4-Mediated Podocyte Depletion in Diabetic Renal Injury , 2013, Diabetes.
[115] R. Testa,et al. MiR-21-5p and miR-126a-3p levels in plasma and circulating angiogenic cells: relationship with type 2 diabetes complications , 2015, Oncotarget.
[116] M. Quintero,et al. Evidence against the involvement of nitric oxide in the modulation of telomerase activity or replicative capacity of human endothelial cells , 2007, Experimental Gerontology.
[117] J. Campisi,et al. Cellular senescence: when bad things happen to good cells , 2007, Nature Reviews Molecular Cell Biology.
[118] Benjamin P. C. Chen,et al. New insights into the roles of ATM and DNA-PKcs in the cellular response to oxidative stress. , 2012, Cancer letters.
[119] P. Petocz,et al. High – glycemic index carbohydrate increases nuclear factor-B activation in mononuclear cells of young , lean healthy subjects 1 – 3 , 2008 .
[120] R. Haynes. Diabetic complications , 2009, Journal of general internal medicine.
[121] E. Lakatta,et al. Proinflammation of Aging Central Arteries: A Mini-Review , 2014, Gerontology.
[122] Gökhan S Hotamisligil,et al. Endoplasmic reticulum stress and atherosclerosis , 2010, Nature Medicine.
[123] R. Holman,et al. 10-year follow-up of intensive glucose control in type 2 diabetes. , 2008, The New England journal of medicine.
[124] G. Ferbeyre,et al. Metformin inhibits the senescence‐associated secretory phenotype by interfering with IKK/NF‐κB activation , 2013, Aging cell.
[125] L. Ignarro,et al. Endothelial cellular senescence is inhibited by liver X receptor activation with an additional mechanism for its atheroprotection in diabetes , 2014, Proceedings of the National Academy of Sciences.
[126] M. Cooper,et al. 50 years forward: mechanisms of hyperglycaemia-driven diabetic complications , 2015, Diabetologia.